Search

everythinglearnresearchcommunity

for

Search:↓

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

The method effectively measures drug impact on DHT levels in prostate treatments.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Optimized film improves finasteride skin absorption and treatment efficiency.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Finasteride can cause skin reactions, so dermatologists should be aware.

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

The FDA did not approve a testosterone drug because of safety concerns.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

GI197111X is best dissolved in Capmul MCM for trials.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

A new method to make Finasteride is more cost-effective and yields 16%.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

SHPro® improved urinary symptoms and erectile function in men and is safe.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Finasteride may reduce prostate cancer risk.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.